Irofulven (MGI 114) : MGI Pharma : Anti-cancer compound (Acylfulvene)

Irofulven Data Presented at AACR-NCI-EORTC 2001 Conference (MGI Pharma)
Press release reviews preclinical and clinical data presented at the 2001 AACR-NCI-EORTC conference on irofulven's antitumor activity and mechanism of action in a variety of cancers, including NSCLC. [11/01]

Irofulven - Recent MEDLINE Abstracts (PubMed)